What are the symptoms of MTHFR (Methylenetetrahydrofolate Reductase) gene mutation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

MTHFR gene mutations can cause a range of symptoms related to impaired methylation processes in the body, and recent evidence suggests that supplementing with methylfolate and methylcobalamin may help alleviate these symptoms. Common symptoms of MTHFR gene mutations include fatigue, muscle pain, cognitive issues like brain fog and memory problems, depression or anxiety, headaches, cardiovascular issues, and pregnancy complications 1. Some people may also experience digestive problems, neuropathy, or autoimmune conditions. However, many individuals with MTHFR mutations have no symptoms at all.

Symptoms and Prevention

To manage MTHFR gene mutation symptoms, consider the following:

  • Increasing folate-rich foods (leafy greens, legumes) in your diet
  • Avoiding folic acid supplements, as they may not be effective for individuals with MTHFR mutations
  • Possibly taking methylfolate (400-1000 mcg daily) and methylcobalamin (B12) supplements, as these have been shown to be beneficial in reducing homocysteine levels and preventing stroke 1
  • Reducing processed foods, managing stress, and avoiding excessive alcohol may also help support proper methylation pathways

Importance of Consultation

It's essential to consult with a healthcare provider before starting any supplement regimen, as individual needs vary based on specific mutation types and overall health status. The healthcare provider can help determine the best course of treatment and recommend the appropriate supplements and dosages.

Recent Evidence

A recent study found that reducing homocysteine levels through supplementation with methylfolate and methylcobalamin can help prevent stroke, particularly in individuals with MTHFR 677 CC carriers 1. Another study suggested that using 5-methyltetrahydrofolate instead of folic acid may be more efficacious in preventing stroke and cognitive decline 1. These findings highlight the importance of considering the latest evidence when developing treatment plans for individuals with MTHFR gene mutations.

From the Research

MTHFR Gene Mutation Symptoms

The MTHFR gene mutation has been associated with various health conditions, including:

  • Cardiovascular disease: Elevated homocysteine levels, which can be caused by the MTHFR gene mutation, are considered an independent risk factor for atherosclerosis 2.
  • Cerebral venous sinus thrombosis (CVST): The MTHFR gene polymorphisms C677T and A1298C have been associated with CVST, with symptoms including headache and seizures 3.
  • Hyperhomocysteinemia: The MTHFR gene mutation can lead to a relative deficiency in the remethylation process of homocysteine into methionine, resulting in mild-to-moderate hyperhomocysteinemia 2.
  • Increased risk of ischemic heart disease (IHD): Individuals with the MTHFR TT genotype have been found to have a higher risk of IHD 4.

Associated Risk Factors

The MTHFR gene mutation has been associated with various risk factors, including:

  • Elevated total cholesterol and low-density lipoprotein cholesterol (LDL) levels 3.
  • Increased homocysteine levels 2, 3, 4.
  • Low serum folate and vitamin B12 levels 2, 4.
  • Inflammatory conditions, such as increased high-sensitive C-reactive protein (hsCRP) levels 3.

Clinical Implications

The MTHFR gene mutation has been found to have significant clinical implications, including:

  • Increased risk of cardiovascular disease and CVST 2, 3, 4.
  • Potential use as a prognostic factor for CVST 3.
  • Importance of considering plasma C-reactive protein level and hyperhomocysteinemia as prognostic factors in CVST 3.
  • Limited clinical indications for testing for the 677C>T and 1298A>C polymorphisms in the MTHFR gene, and not recommended as a non-specific screening test in the asymptomatic general population 5.

Related Questions

Are fluctuating blood pressure and cardiovascular issues associated with MTHFR (Methylenetetrahydrofolate Reductase) mutations?
How do you diagnose Methylenetetrahydrofolate Reductase (MTHFR) and Catechol-O-Methyltransferase (COMT) gene mutations in a patient?
What is the optimal timing and administration of L-methylfolate (L-methyl tetrahydrofolate) 7.5 milligrams in relation to food intake for individuals with a Methylenetetrahydrofolate Reductase (MTHFR) gene variant?
Is MTHFR (methylenetetrahydrofolate reductase) testing still indicated?
What are the management options for a patient with a mutation in the MTHFR (methylenetetrahydrofolate reductase) gene?
Why do patients with myasthenia gravis take Bactrim (trimethoprim/sulfamethoxazole) weekly?
What is the clinical presentation of vitamin A deficiency (VAD)?
What is the mortality rate of sepsis (Systemic Inflammatory Response Syndrome) following Pseudomonas aeruginosa wound infection?
What is the cause of my persistent morning erections, also known as nocturnal penile tumescence (NPT), for 15 years?
What are the implications of Pseudomonas infection in a hemodialysis (HD) vascular access?
What is the next step for an 80-year-old male patient presenting with severe abdominal pain, loss of consciousness, fever (hyperthermia), tachypnea (respiratory rate of 23 breaths per minute), tachycardia (pulse of 120 beats per minute), hypotension (blood pressure of 100/70 mmHg), and a rigid and tender abdomen, suggestive of acute mesenteric ischemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.